Voyager Therapeutics, Inc. - COM (VYGR)

Historical Portfolio Holders from Q4 2015 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
37.1M
Holdings value Q2 2024
$293M
Value change Q2 2024
+$18.9M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
125
Number of buys Q2 2024
64
Number of sells Q2 2024
-67
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 12.3K $72K +$9.1K $5.83 1
2024 Q2 37.1M $293M +$18.9M $7.91 125
2024 Q1 34.5M $321M +$80.4M $9.31 131
2023 Q4 25.9M $219M -$3.56M $8.44 107
2023 Q3 26.2M $203M +$537K $7.75 110
2023 Q2 25.8M $296M +$49M $11.45 105
2023 Q1 22.8M $175M -$69.4K $7.71 83
2022 Q4 22.9M $139M -$700K $6.10 68
2022 Q3 23M $136M +$348K $5.92 66
2022 Q2 22.9M $136M +$8.18M $5.91 73
2022 Q1 21.2M $162M +$28.9M $7.62 67
2021 Q4 17.6M $47.7M -$9.6M $2.71 51
2021 Q3 21.3M $56.1M -$4.61M $2.63 62
2021 Q2 22.7M $93.7M -$15.7M $4.13 71
2021 Q1 26.1M $123M -$6.91M $4.71 93
2020 Q4 27.3M $195M -$7.12M $7.15 93
2020 Q3 27.7M $296M -$21.2M $10.67 105
2020 Q2 29.5M $372M -$3.23M $12.62 106
2020 Q1 29.9M $274M -$8.84M $9.15 114
2019 Q4 30.5M $425M -$4.98M $13.95 132
2019 Q3 30.4M $523M +$3.41M $17.21 127
2019 Q2 29M $788M +$142M $27.22 122
2019 Q1 27.2M $520M +$3.42M $19.14 110
2018 Q4 27.8M $261M -$17.1M $9.40 112
2018 Q3 28.9M $547M -$4.05M $18.92 117
2018 Q2 29.1M $569M +$41.4M $19.54 125
2018 Q1 27.1M $509M +$37M $18.79 108
2017 Q4 25.2M $418M +$68.4M $16.60 98
2017 Q3 11.3M $233M +$24.1M $20.59 74
2017 Q2 10.9M $98.1M -$1.7M $8.96 51
2017 Q1 11.1M $146M +$8.71M $13.24 45
2016 Q4 11M $140M +$4.08M $12.74 54
2016 Q3 10.6M $128M +$782K $12.01 50
2016 Q2 10.6M $116M +$5.91M $10.99 48
2016 Q1 10M $87M -$3.38M $8.73 41
2015 Q4 10.4M $225M +$220M $21.90 34